Bio-View Ltd (TLV:BIOV)
23.30
-0.10 (-0.43%)
Aug 14, 2025, 5:24 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 31.36 million as of August 14, 2025. Its market cap has decreased by -3.18% in one year.
Market Cap
31.36M
Enterprise Value
22.40M
Revenue
25.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.30
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 31.36M, a decrease of -47.56%. That is a compound annual growth rate of -3.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 31.22M | -12.51% |
Dec 31, 2024 | 35.69M | -21.62% |
Dec 31, 2023 | 45.53M | -10.12% |
Dec 29, 2022 | 50.66M | 13.09% |
Dec 30, 2021 | 44.79M | -20.07% |
Dec 31, 2020 | 56.04M | 29.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 66.82B |
Danel (Adir Yeoshua) | 2.69B |
Kamada | 1.47B |
Bait Bakfar | 1.06B |
SofWave Medical | 1.01B |
BrainsWay | 839.24M |
Novolog (Pharm-Up 1966) | 712.16M |
Ilex Medical | 672.96M |